Changes in Sensitivity, Taste and Smell in Stroke Patients
Launched by UNIVERSITY OF GIESSEN · Aug 1, 2017
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a recent stroke can affect a person’s ability to swallow, as well as their sense of taste and smell. The researchers will look at stroke patients who have had a new stroke within the last 72 hours. They will use special tests to evaluate how well patients can swallow and how sensitive they are to tastes and smells. Younger and older healthy volunteers will also participate to help compare results.
To be eligible for this study, stroke patients must be able to give their consent and have a recent stroke confirmed by a brain scan. However, those with previous strokes or swallowing difficulties, certain brain issues, allergies to smells or flavors, or those who cannot undergo specific tests will not be part of the trial. Participants will have the opportunity to contribute to important research that may help improve understanding of how strokes impact swallowing and sensory experiences.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Volunteers:
- • informed consent
- Stroke patients:
- • informed consent
- • new supratentorial stroke (\<72 hours old) confirmed by CT (computed tomography) or MRI (magnetic resonance imaging)
- Exclusion Criteria:
- • pre-existing stroke oder dysphagia
- • extensive white matter lesions in CT- or MRI-scan
- • allergies to odorous substances or flavoring
- • contraindications for FEES (flexible endoscopic evaluation of swallowing), CT or MRI (stroke patients only)
About University Of Giessen
The University of Giessen, a prominent research institution in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including medicine, pharmacology, and public health, to conduct rigorous studies aimed at improving patient outcomes. Committed to maintaining the highest ethical standards and regulatory compliance, the University of Giessen fosters a research environment that encourages scientific inquiry and the translation of findings into clinical practice, ultimately contributing to the advancement of healthcare and therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gießen, Hessen, Germany
Patients applied
Trial Officials
Tobias Braun, M.D.
Principal Investigator
University Giessen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials